Zobrazeno 1 - 10 of 43 pro vyhledávání: '"Dov Flex"'
1
Akademický článek
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Autor: Dan Aravot, Yaron D. Barac, Efrat Krutzwald-Josefson, Aaron M. Allen, Dov Flex, Nir Peled, Mordechai R. Kramer, Yuri Peysakhovich, Milton Saute
Publikováno v: Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Introduction Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate. Hypothesis Neo adjuvant (NA) treatment given pre-pneumonectom
Externí odkaz: https://doaj.org/article/3e5a3e5dc08b47e98002970f0d307d4d
Zobrazit plný text záznamu
2
Akademický článek
Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Autor: Dan Aravot, Yaron D. Barac, Efrat Krutzwald-Josefson, Aaron M. Allen, Dov Flex, Nir Peled, Mordechai R. Kramer, Yuri Peysakhovich, Milton Saute
Publikováno v: Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-1 (2019)
The original article [1] contained an error whereby all authors’ names were mistakenly inverted. This error has now been corrected.
Externí odkaz: https://doaj.org/article/3753c556bbf147f6a14e2201a135d4d2
Zobrazit plný text záznamu
3
Prophylactic Topical Treatment for EGFR Inhibitor-Induced Papulopustular Rash: A Randomized Clinical Trial
Autor: Irit Ben-Aharon, Hadas Prag-Naveh, Nir Peled, Salomon M. Stemmer, E. Hodak, Dov Flex, Baruch Brenner, Batya Davidovici, Aron Popovtzer, Ofer Purim, Igor Snast, Iris Amitay-Laish, Michael David, Yael Anne Leshem, Ayelet Ollech
Publikováno v: Dermatology. 237:988-994
Background: The incidence of epidermal growth factor receptor inhibitor (EGFRI)-induced papulopustular rash is 60–85%. Objective: To investigate prophylactic topical treatment for EGFRI-induced rash. Methods: A single-center, randomized, double-bli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c150ed3926bc7bc2b4df9cc7a9c9ce
https://doi.org/10.1159/000511869
Zobrazit plný text záznamu
4
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Autor: Yuri Peysakhovich, Efrat Krutzwald-Josefson, Milton Saute, Mordechai R. Kramer, Nir Peled, Aaron M. Allen, Dan Aravot, Dov Flex, Yaron D. Barac
Publikováno v: Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-7 (2019)
Journal of Cardiothoracic Surgery
Introduction Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate. Hypothesis Neo adjuvant (NA) treatment given pre-pneumonectomy does no
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99752617eba6ce56eb4e78d90530b86
http://link.springer.com/article/10.1186/s13019-018-0829-z
Zobrazit plný text záznamu
5
Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Autor: Efrat Krutzwald-Josefson, Aaron M. Allen, Milton Saute, Nir Peled, Yuri Peysakhovich, Mordechai R. Kramer, Yaron D. Barac, Dan Aravot, Dov Flex
Publikováno v: Journal of Cardiothoracic Surgery
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-1 (2019)
Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate.Neo adjuvant (NA) treatment given pre-pneumonectomy does not increase surgical compl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51bb15c2d5ea2c2f8bed7f5fbd92189
https://doi.org/10.1186/s13019-019-0856-4
Zobrazit plný text záznamu
6
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer
Autor: Aaron M. Allen, Milton Saute, Tzippy Shochat, Alona Zer, Nir Peled, Dov Flex, Elizabeta Dudnik, Mordechai R. Kramer, Eyal Fenig
Publikováno v: Oncology. 95(1)
Background: Trimodality therapy (chemoradiation followed by surgery) provides a benefit in progression-free survival but not overall survival. We sought to determine if a high dose of radiation could be delivered safely and provide a clinical benefit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1fa2bde27f4b0fec6fcf757dfe80e6
https://pubmed.ncbi.nlm.nih.gov/29680834
Zobrazit plný text záznamu
7
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
Autor: Mahmood Abu-Amna, Tzippy Shochat, Sivan Shamai, Mor Moskovitz, Elizabeth Dudnik, Ofer Merimsky, Ahuva Grubstein, Daniel A. Goldstein, Ariel Hammerman, Yelena Shechtman, Alona Zer, Ekaterina Hanovich, Mira Wollner, Dov Flex, Nir Peled, Arnold Cyjon, Laila C. Roisman, Jair Bar, Sameh Daher
Publikováno v: Lung cancer (Amsterdam, Netherlands). 126
Objectives Nivolumab has recently received regulatory approval as a 2nd-line treatment of non-small cell lung cancer (NSCLC). The data regarding its effectiveness and safety in real life setting is lacking. Materials and methods 260 consecutive patie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614d5d3af2e4e2a28b664e1e2075a77d
https://pubmed.ncbi.nlm.nih.gov/29254746
Zobrazit plný text záznamu
9
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Autor: Hovav Nechushtan, Nir Peled, Dov Flex, Daniel A. Goldstein, Shlomit Yust-Katz, Elizabeth Dudnik, Tali Siegal, Alona Zer
Publikováno v: Lung cancer (Amsterdam, Netherlands). 98
Central nervous system (CNS) metastases occur in 30% of patients with advanced non-small cell lung cancer (NSCLC). Localized treatments targeting CNS metastases result in delays in systemic therapy administration and are associated with neurocognitiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f10e757eba6f2edf451336f339b481b
https://pubmed.ncbi.nlm.nih.gov/27393516
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje